DK0563389T3 - Farmaceutisk aerosolkomposition og dens anvendelse til behandling og profylakse af virussygdomme - Google Patents

Farmaceutisk aerosolkomposition og dens anvendelse til behandling og profylakse af virussygdomme

Info

Publication number: DK0563389T3
Authority: DK; Denmark
Prior art keywords: prophylaxis; treatment; viral diseases; aerosol composition; pharmaceutical aerosol
Prior art date: 1991-08-21

Application number

DK92919013.0T

Other languages

Danish (da)

English (en)

Inventor

Alexandr V Ovcharenko

Oleg Petrovich Zhirnov

Original Assignee

Oleg Petrovich Zhirnov

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-08-21

Filing date

1992-08-19

Publication date

1996-09-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21584787&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0563389(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1992-08-19 Application filed by Oleg Petrovich Zhirnov filed Critical Oleg Petrovich Zhirnov

1996-09-30 Application granted granted Critical

1996-09-30 Publication of DK0563389T3 publication Critical patent/DK0563389T3/da

Links

238000011321 prophylaxis Methods 0.000 title abstract 2
238000011282 treatment Methods 0.000 title abstract 2
230000003612 virological effect Effects 0.000 title abstract 2
201000010099 disease Diseases 0.000 title 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
239000000203 mixture Substances 0.000 title 1
239000008249 pharmaceutical aerosol Substances 0.000 title 1
239000013543 active substance Substances 0.000 abstract 2
239000007864 aqueous solution Substances 0.000 abstract 2
108010039627 Aprotinin Proteins 0.000 abstract 1
229960004405 aprotinin Drugs 0.000 abstract 1
ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 abstract 1
239000002245 particle Substances 0.000 abstract 1
239000000137 peptide hydrolase inhibitor Substances 0.000 abstract 1
208000023504 respiratory system disease Diseases 0.000 abstract 1
239000007787 solid Substances 0.000 abstract 1
239000000126 substance Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Otolaryngology (AREA)
Pulmonology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK92919013.0T 1991-08-21 1992-08-19 Farmaceutisk aerosolkomposition og dens anvendelse til behandling og profylakse af virussygdomme DK0563389T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SU5000531/14A RU2054180C1 (ru)	1991-08-21	1991-08-21	Способ лечения вирусных респираторных инфекций

Publications (1)

Publication Number	Publication Date
DK0563389T3 true DK0563389T3 (da)	1996-09-30

Family

ID=21584787

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK92919013.0T DK0563389T3 (da)	1991-08-21	1992-08-19	Farmaceutisk aerosolkomposition og dens anvendelse til behandling og profylakse af virussygdomme

Country Status (9)

Country	Link
US (1)	US5723439A (fr)
EP (1)	EP0563389B1 (fr)
JP (1)	JP2774379B2 (fr)
AT (1)	ATE137958T1 (fr)
AU (1)	AU2517792A (fr)
DE (1)	DE69210802T2 (fr)
DK (1)	DK0563389T3 (fr)
RU (1)	RU2054180C1 (fr)
WO (1)	WO1993003708A1 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL99864A (en) *	1990-10-31	2000-11-21	Autoimmune Inc	Compositions for suppressing transplant rejection in mammals which contain tissue donor derived MHC antigens
JPH09501418A (ja) *	1993-07-19	1997-02-10	アムジエン・インコーポレーテツド	エアゾル化タンパク質の安定化
DK0891426T3 (da)	1996-03-11	2006-10-02	Bayer Corp	Humant bikunin
RU2140273C1 (ru) *	1996-11-06	1999-10-27	Закрытое акционерное общество "АЭРОМЕД"	Способ лечения простудных заболеваний
DE19830694A1 (de) *	1998-07-09	2000-01-13	Bayer Ag	Substituierte Acylaminophenyl-uracile
JP3819239B2 (ja) *	1998-12-22	2006-09-06	バイエルアクチェンゲゼルシャフト	粘膜線毛クリアランスの速度を促進する方法
WO2002017958A1 (fr) *	2000-08-29	2002-03-07	Max-Delbrück-Centrum für Molekulare Medizin	Agent capable d'influencer l'angiogenese
EP1438019A1 (fr) *	2001-10-24	2004-07-21	PARI GmbH Spezialisten für effektive Inhalation	Trousse de preparation de composition pharmaceutique
US8084036B2 (en)	2002-11-22	2011-12-27	Nexbio, Inc.	Broad spectrum anti-viral therapeutics and prophylaxis
US8512710B2 (en)	2002-11-22	2013-08-20	Ansun Biopharma, Inc.	Class of therapeutic protein based molecules
US7807174B2 (en)	2002-11-22	2010-10-05	Nexbio, Inc.	Class of therapeutic protein based molecules
MD3381G2 (ro) *	2006-06-19	2008-03-31	Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова	Metodă de tratament al parotiditei cronice la copii
EP2371857A1 (fr) *	2010-04-01	2011-10-05	CSL Behring GmbH	Inhibiteurs de facteur XII pour traiter la maladie de poumon interstitiel
RU2425691C1 (ru) *	2010-07-15	2011-08-10	ВАКЕ спол с.р.о.	Аэрозольный препарат на основе апротинина для лечения вирусных респираторных инфекций
EP2714716B1 (fr) *	2011-06-02	2018-04-11	Socpra Sciences Santé Et Humaines S.E.C.	Inhibiteurs de matriptase et utilisations de ceux-ci contre les infections à orthomyxoviridae
RU2657523C2 (ru) *	2011-11-03	2018-06-14	Олег Петрович Жирнов	Фармацевтический аэрозольный состав ингибиторов протеаз с озон-сберегающим пропеллентом и его получение
DE202012013134U1 (de)	2012-11-01	2014-12-05	Oleg Petrovich Zhirnov	Pharmazeutische Aerosolformulierung von Protease-Inhibitoren und deren Zubereitung
TWI718086B (zh)	2013-01-07	2021-02-11	英屬維爾京群島商遠東超級實驗室有限公司	通過干擾素的經皮和/或經粘膜給藥治療骨癌、皮膚癌、皮下癌、粘膜癌和/或粘膜下癌的方法和組合物
RU2711080C2 (ru) *	2015-06-15	2020-01-15	Олег Петрович Жирнов	Комбинированный аэрозольный состав на основе ингибиторов протеаз и его получение
RU2738885C1 (ru) *	2020-04-30	2020-12-18	Андрей Александрович Иващенко	Противо-SARS-CoV-2 вирусное средство Антипровир
US20220000993A1 (en) *	2020-07-06	2022-01-06	Torvald Ranta Foretagsjuridik AB	Drug for use against the novel coronavirus disease, covid-19
US20240415944A1 (en) *	2021-04-06	2024-12-19	Andrey Alexandrovich Ivashchenko	Aqueous aprotinin-containing antiviral pharmaceutical composition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE556587A (fr) *	1957-01-31	1957-04-11
DE2654124A1 (de) *	1976-11-29	1978-06-01	Bayer Ag	Derivate des trypsin-kallikrein-inhibitors aus rinderorganen (bpti) mit proteasenhemmwirkung und antiphlogistischer wirkung, ihre herstellung und ihre verwendung als arzneimittel
ZA815698B (en) *	1980-08-28	1983-04-27	Lilly Co Eli	Intranasal formulation
DE3175003D1 (en) *	1981-06-25	1986-08-28	Serapharm Gmbh & Co Kg	Enriched plasma derivative for promoting wound sealing and wound healing
JPS59163313A (ja) *	1983-03-09	1984-09-14	Teijin Ltd	経鼻投与用ペプチドホルモン類組成物
US5262157A (en) *	1987-03-26	1993-11-16	Sloan-Kettering Institute For Cancer Research	Method of preventing Pneumocystis carinii pneumonia using pentamidine in an aerosol form
JP2656944B2 (ja) *	1987-04-30	1997-09-24	クーパーラボラトリーズ	タンパク質性治療剤のエアロゾール化
JP2804979B2 (ja) *	1988-11-28	1998-09-30	日本ケミカルリサーチ株式会社	エイズ治療および阻害剤
FR2646354B1 (fr) *	1989-04-27	1994-06-10	Sanofi Sa	Utilisation de peptides inhibiteurs de proteases acides pour la preparation de medicaments utiles pour le traitement de maladies virales
CS275231B2 (en) *	1989-09-29	1992-02-19	Ustav Makormolekularni Chemie	Medicine bottle
DE4117078A1 (de) *	1991-05-25	1992-11-26	Boehringer Ingelheim Kg	Verfahren zur herstellung therapeutisch anwendbarer aerosole

1991
- 1991-08-21 RU SU5000531/14A patent/RU2054180C1/ru active
1992
- 1992-08-19 US US08/039,393 patent/US5723439A/en not_active Expired - Lifetime
- 1992-08-19 AU AU25177/92A patent/AU2517792A/en not_active Abandoned
- 1992-08-19 AT AT92919013T patent/ATE137958T1/de active
- 1992-08-19 EP EP92919013A patent/EP0563389B1/fr not_active Expired - Lifetime
- 1992-08-19 DK DK92919013.0T patent/DK0563389T3/da active
- 1992-08-19 DE DE69210802T patent/DE69210802T2/de not_active Expired - Lifetime
- 1992-08-19 JP JP5504250A patent/JP2774379B2/ja not_active Expired - Lifetime
- 1992-08-19 WO PCT/RU1992/000164 patent/WO1993003708A1/fr not_active Ceased

Also Published As

Publication number	Publication date
EP0563389B1 (fr)	1996-05-15
RU2054180C1 (ru)	1996-02-10
US5723439A (en)	1998-03-03
AU2517792A (en)	1993-03-16
JPH06506474A (ja)	1994-07-21
WO1993003708A1 (fr)	1993-03-04
DE69210802D1 (de)	1996-06-20
EP0563389A1 (fr)	1993-10-06
EP0563389A4 (en)	1993-10-20
JP2774379B2 (ja)	1998-07-09
ATE137958T1 (de)	1996-06-15
DE69210802T2 (de)	1997-01-16

Publication	Publication Date	Title
DK0563389T3 (da)	1996-09-30	Farmaceutisk aerosolkomposition og dens anvendelse til behandling og profylakse af virussygdomme
ATE128350T1 (de)	1995-10-15	Pharmazeutische aerosolformulierung.
BG102689A (bg)	1999-02-26	Фармацевтичен аерозолен състав за използване при лечение на респираторни смущения
ATE401093T1 (de)	2008-08-15	Extrakte, wirkstoffe und pharmazeutische präparate mit antidiabetischen eigenschaften und ihre verwendung
ATE61050T1 (de)	1991-03-15	Pyridazinamine wirksam gegen viren.
GR3006177T3 (fr)	1993-06-21
GR3032207T3 (en)	2000-04-27	2-Bromomelatonin in the therapy of sleep disorders
GEP20002298B (en)	2000-11-25	Benzimidazole Derivatives, Method of Their Production, Pharmaceutical Composition Containing the Same and Method for Its Treatment
ZA948669B (en)	1995-07-04	New pyrazine carboxamide derivatives the preparation thereof and their use in pharmaceutical compositions
IL91276A0 (en)	1990-03-19	Pharmaceutical compositions containing alpha-amino boronic acid derivatives,for the prophylaxis and treatment of virus diseases
MD707B2 (en)	1997-04-30	Sulphonylurea derivatives, process for their preparation, the intermediate products for them, the herbicide and plants growing suppressing remedy on their base, weeds control process
DE68902531D1 (de)	1992-09-24	Dispergierbare zubereitung.
SE8404065D0 (sv)	1984-08-10	Novel biologically active compounds
IL126235A (en)	2003-02-12	Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use
NO912414D0 (no)	1991-06-20	Forbindelse med mavesyreinhiberende effekt og fremgangsmaate for dens fremstilling.
DK0667155T3 (da)	2000-09-11	Tabletter med thioctsyre med bestemt kornstørrelse
ITRM910430A1 (it)	1992-12-17	Composizioni farmaceutiche di somatostatina con assorbimento migliorato, loro preparazione e loro impiego
SE8600658D0 (sv)	1986-02-14	Novel composition of matter
IT1251226B (it)	1995-05-05	Composizioni farmaceutiche contenenti clozapina, loro preparazione e loro impiego
DK0533896T3 (fr)	1997-02-17
ZA857040B (en)	1986-04-30	Compositions killing or inhibiting the growth of microorganisms and the use thereof
ATE37185T1 (de)	1988-09-15	Kontrazeptive zusammensetzungen auf basis von levo-norgestrel-estern.
JPS6456622A (en)	1989-03-03	Percutaneous absorbefacient base composition
IL111138A (en)	1997-04-15	Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
ATE224716T1 (de)	2002-10-15	Pharmazeutische zusammensetzungen von cinchonin dihydrochlorid